IMED Stock Overview
A research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Imed Infinity Medical-Limited Partnership Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.94 |
| 52 Week High | ₪1.89 |
| 52 Week Low | ₪0.58 |
| Beta | 0.084 |
| 1 Month Change | -10.24% |
| 3 Month Change | n/a |
| 1 Year Change | 4.69% |
| 3 Year Change | -71.51% |
| 5 Year Change | n/a |
| Change since IPO | -90.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| IMED | IL Medical Equipment | IL Market | |
|---|---|---|---|
| 7D | -8.9% | 0.1% | 0.5% |
| 1Y | 4.7% | 18.0% | 23.7% |
Return vs Industry: IMED underperformed the IL Medical Equipment industry which returned 19% over the past year.
Return vs Market: IMED underperformed the IL Market which returned 23% over the past year.
Price Volatility
| IMED volatility | |
|---|---|
| IMED Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in IL Market | 8.0% |
| 10% least volatile stocks in IL Market | 3.0% |
Stable Share Price: IMED's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: Insufficient data to determine IMED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 55 | Itay Gal-Or | www.infinitymedical.co.il/ |
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Imed Infinity Medical-Limited Partnership Fundamentals Summary
| IMED fundamental statistics | |
|---|---|
| Market cap | ₪3.78m |
| Earnings (TTM) | -₪4.30m |
| Revenue (TTM) | n/a |
-2.1x
P/S Ratio-0.9x
P/E RatioIs IMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMED income statement (TTM) | |
|---|---|
| Revenue | -US$495.00k |
| Cost of Revenue | US$0 |
| Gross Profit | -US$495.00k |
| Other Expenses | US$687.00k |
| Earnings | -US$1.18m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 100.00% |
| Net Profit Margin | 238.79% |
| Debt/Equity Ratio | 0% |
How did IMED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 09:14 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imed Infinity Medical-Limited Partnership is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|